BiferaRx (Meda Pharmaceuticals)
Welcome to the PulseAid listing for the BiferaRx drug offered from Meda Pharmaceuticals. This Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Meda Pharmaceuticals |
| NON-PROPRIETARY NAME: | folic acid, cyanocobalamin, iron dextran and heme iron polypeptide |
| SUBSTANCE NAME: | FOLIC ACID; CYANOCOBALAMIN; IRON DEXTRAN; HEME IRON POLYPEPTIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
| START MARKETING DATE: | 2012-10-31 |
| END MARKETING DATE: | 0000-00-00 |
BiferaRx HUMAN PRESCRIPTION DRUG Details:
| Item Description | BiferaRx from Meda Pharmaceuticals |
| LABELER NAME: | Meda Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1; 25; 22; 6(mg/1; ug/1; mg/1; mg/1) |
| START MARKETING DATE: | 2012-10-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0037-6885_3dbec270-2747-4c24-a288-9e80ba23ecd9 |
| PRODUCT NDC: | 0037-6885 |
| APPLICATION NUMBER: | |
Other FOLIC ACID; CYANOCOBALAMIN; IRON DEXTRAN; HEME IRON POLYPEPTIDE Pharmaceutical Manufacturers / Labelers:
